David P. Snow
2019
In 2019, David P. Snow earned a total compensation of $1.9M as Chief Business Officer at Sevion Therapeutics, a 54% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $78,000 |
|---|---|
| Option Awards | $1,080,700 |
| Salary | $388,750 |
| Stock Awards | $288,250 |
| Other | $48,505 |
| Total | $1,884,205 |
Snow received $1.1M in option awards, accounting for 57% of the total pay in 2019.
Snow also received $78K in non-equity incentive plan, $388.8K in salary, $288.3K in stock awards and $48.5K in other compensation.
Rankings
In 2019, David P. Snow's compensation ranked 6,231st out of 13,971 executives tracked by ExecPay. In other words, Snow earned more than 55.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,231 out of 13,971 | 55th |
Division Manufacturing | 2,339 out of 5,695 | 59th |
Major group Chemicals And Allied Products | 853 out of 2,194 | 61st |
Industry group Drugs | 720 out of 1,880 | 62nd |
Industry Biological Products, Except Diagnostic Substances | 168 out of 389 | 57th |
Source: SEC filing on April 1, 2020.
Snow's colleagues
We found three more compensation records of executives who worked with David P. Snow at Sevion Therapeutics in 2019.